Table 1 Patients with lung NET, Na
MarketScan | PharMetrics | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | |
N | 435 | 521 | 681 | 796 | 667 | 687 | 419 | 510 | 563 | 598 | 616 | 648 |
Age, year, no. (%) | ||||||||||||
18–24 | 9 (2.1) | 6 (1.2) | 9 (1.3) | 9 (1.1) | 7 (1.0) | 2 (0.3) | 7 (1.7) | 5 (1.0) | 10 (1.8) | 10 (1.7) | 7 (1.1) | 9 (1.4) |
25–34 | 16 (3.7) | 27 (5.2) | 26 (3.8) | 37 (4.6) | 26 (3.9) | 30 (4.4) | 29 (6.9) | 18 (3.5) | 23 (4.1) | 19 (3.2) | 27 (4.4) | 17 (2.6) |
35–44 | 44 (10.1) | 57 (10.9) | 67 (9.8) | 75 (9.4) | 68 (10.2) | 79 (11.5) | 38 (9.1) | 59 (11.6) | 46 (8.2) | 61 (10.2) | 65 (10.6) | 60 (9.3) |
45–54 | 117 (26.9) | 152 (29.2) | 205 (30.1) | 217 (27.3) | 182 (27.3) | 198 (28.8) | 123 (29.4) | 136 (26.7) | 156 (27.7) | 166 (27.8) | 165 (26.8) | 162 (25.0) |
55–64 | 249 (57.2) | 279 (53.6) | 374 (54.9) | 458 (57.5) | 384 (57.6) | 378 (55.0) | 222 (53.0) | 292 (57.3) | 328 (58.3) | 342 (57.2) | 352 (57.1) | 400 (61.7) |
Female | 260 (59.8) | 340 (65.3) | 445 (65.3) | 515 (64.7) | 463 (69.4) | 459 (66.8) | 258 (61.6) | 315 (61.8) | 352 (62.5) | 392 (65.6) | 403 (65.4) | 435 (67.1) |